$4.09-0.73%
2026-10-05 closeLoading chart…
Today's signals · No active technical signal.
Signal details →Passage Bio last closed at $4.09 (-0.73%) on 2026-10-05. Listed on Nasdaq. Trailing 12 months PER is -0.4×. Its overall grade ranks 679 of 741 stocks in Healthcare.
About this company
Passage Bio last closed at $4.09 (-0.73%) on 2026-10-05. Listed on Nasdaq.
Details →Reported results
Details →
Position in sector
Healthcare · Overall F · 679/741
Valuation grade D
Related stocks
- Astellas PharmaCustomer
Passage Bio의 유전자치료 파이프라인과 관련해 공동개발·사업화 파트너로 거론되는 대형 제약사
- Sarepta TherapeuticsCompetitor
희귀 유전질환·유전자치료 영역에서 경쟁하는 바이오텍
- Rocket PharmaceuticalsCompetitor
희귀 유전질환 대상 유전자치료 개발 경쟁사
About Passage Bio
- What technical signals does Passage Bio (PASG) have?
- Passage Bio current technical signals: no active technical signal.
- Is Passage Bio a cup-and-handle pattern?
- No. Passage Bio has no valid Cup signal right now.
- What published figures are available for Passage Bio?
- Market cap: $13M. Trailing 12 months PER: -0.4×. Latest quarter PBR: 2.95×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Passage Bio, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.
Quantus Signal · live data · not investment advice · Privacy Policy